| Genomic Health to Present at Two Upcoming Investor Conferences (PR Newswire) Genomic Health, Inc. today announced that members of its management team will present at the following conferences in June: us.rd.yahoo.com |
Life Technologies Q2 2010 Earnings Call Transcript Life Technologies (LIFE)Q2 2010 Earnings CallJuly 29, 2010 8:30 am ETComplete Story » seekingalpha.com |
Chelsea Could Benefit From FDA Proposition BioShockers submits:On Monday, the US Food and Drug Administration announced a proposition to pull ProAmitine (Midodrine) from the market due to Shire (SHPGY) not conducting post-approval studies to prove that the drug has a benefit. Midodrine is currently the only FDA-approved drug for Orthostatic Hypotension. It was approved in 1996 as part of a shorter approval process under the condition that Shire conduct post-approval studies. Midodrine never was a big seller for Shire, and post-approval studies were never conducted. Midodrine was bringing in around $60M/yr as of 2005. FDA stated that around 100,000 patients filled prescriptions for brand or generic Midodrine in 2009. Take note that if the FDA withdraws the medicine's approval, generic companies including Mylan Pharmaceuticals (MYL), Impax Laboratories (IPXL), and Novartis (NVS) unit Sandoz must stop selling their generic versions of Midodrine. Complete Story » seekingalpha.com |
SuperBaby is Back for National Window Covering Safety Month - Video Parents and caregivers are being reminded of potential window-cord dangers and are urged to make the right choice and only use cordless window products in homes with young children. feedproxy.google.com |
Exercise Combination Cuts Blood Sugar in Type 2 Diabetics Combining aerobic exercise and resistance training lowered blood sugar levels in people with type 2 diabetes, a new study has found. online.wsj.com |